Sartorius CellGenix GmbH

General information
Sartorius CellGenix GmbH
Am Flughafen 16
79108 Freiburg, Baden-Württemberg
Germany

Contact person: Felicia M. Rosenthal, Managing Director
Company main phone: +49 (761) 888890
Company main fax:  +49 (761) 88889830
Website:  www.cellgenix.com
Year founded:1994
Source of foundation:Spin-off from public institution / NPO
Name of foundation source:Freiburg University Medical Center
Corporate description / mission:
Sartorius CellGenix is a supplier of raw and ancillary materials for the expanding market of cell and gene therapy and regenerative medicine. The company develops, manufactures and markets human cytokines, growth factors, and other recombinant cell culture components in preclinical and GMP quality as well as proprietary serum-free media for further manufacturing of ATMPs. The company’s products are used by academia and industry partners in clinical trials and commercial manufacturing throughout the world.
In July 2021 the life science group Sartorius acquired a majority stake in CellGenix.
State of ownership: Subsidiary
Headquarters: No
Categorization
Sector:
  • Supplier & Engineering
Subsector:
  • Laboratory consumables and reagents
Business model:
  • Manufacturer
  • R&D
  • Service company
  • Supplier / Distributor
Customer segments:
  • Other
  • Large biotech & big pharma
  • Small biotech
Distribution:
  • Direct (own sales force)
  • Indirect (independent dealer)
Summary Products / Services / Technologies
Description of products:
Pluripotent Stem Cells (iPSC/ESC)
CellGenix® GMP DC Medium
CellGenix® GMP SCGM, etc.
Collaborations & Clients
Partnering strategy / collaborations:
Saint-Gobain Life Sciences
ISCT
ARM, etc.
X